Hi all, It’s been quite a while since I had to think about any of this, but my recollection is that UCSF was almost entirely hands-off regarding third-party plugin licensing (ISOLDE makes extensive use of the ChimeraX Python and C++ APIs). As long as the end user has a license for ChimeraX, as far as I’m aware the plugin developer is free to set more or less whatever license terms they like, as long as they’re legally sensible. They definitely don’t ask for any rights over your software nor any share in the revenue stream. Best, Tristan On Tue, 23 Jan 2024 at 02:52, Tom Goddard <goddard@sonic.net> wrote:
Hi Jacky,
I am not sure how the licensing of commercial bundles works. I think the ISOLDE ChimeraX bundle is commercially licensed to companies and Tristan Croll who wrote that bundle may have some ideas about how that works.
I am the developer of the builtin ChimeraX virtual reality and augmented reality ( https://www.rbvi.ucsf.edu/chimerax/data/looksee-mar2023/looksee.html) capabilities and if you have technical questions about AR/VR in ChimeraX I am happy to discuss.
Tom
On Jan 21, 2024, at 6:02 PM, Jacky Chen via ChimeraX-users < chimerax-users@cgl.ucsf.edu> wrote:
Dear Team ChimeraX,
My name is Jacky Chen, and I am the sales representative at Oomii. Recently, we initiated a project aimed at developing an innovative ChimeraX plugin, specifically designed to enable interactive augmented reality features. To this end, Oomii has acquired two commercial licenses of ChimeraX in January 2024.
As we progress, our intention is to offer the developed bundle for commercial sale to other users. However, upon reviewing the documentation available at: https://www.cgl.ucsf.edu/chimerax/docs/devel/writing_bundles.html, we noticed that it does not specify the licensing particulars for a bundle that utilizes both the ChimeraX API and proprietary code developed by Oomii.
We are keen to ensure that our operations align with ChimeraX's licensing policies. Could you please provide guidance on the business rules that apply to the commercial distribution of such plugins? Additionally, if available, could you direct us to any precedent or contact information for companies that have navigated similar pathways?
Your assistance in this matter is invaluable to us, and we eagerly await your insights.
Thank you very much for your time and support.
Warm regards,
*Jacky Chen 陳志傑*
*Sales Representative*
* <https://oomii.com/>* *jackychen@oomii.com <jackychen@oomii.com>*
*2F.-1, No.94, Baozhong Rd. Xindian Dist., New Taipei City, Taiwan <https://www.google.com/maps/search/2F.-1,+No.94,+Baozhong+Rd.+Xindian+Dist.,...> 23144* *+886-2-8911-2347*
<https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaig...> 乾淨無病毒。www.avast.com <https://www.avast.com/sig-email?utm_medium=email&utm_source=link&utm_campaig...> _______________________________________________ ChimeraX-users mailing list -- chimerax-users@cgl.ucsf.edu To unsubscribe send an email to chimerax-users-leave@cgl.ucsf.edu Archives: https://mail.cgl.ucsf.edu/mailman/archives/list/chimerax-users@cgl.ucsf.edu/
-- Altos Labs UK Limited | England | Company reg 13484917 Registered address: 3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom, WA14 2DT